IP Library › Granted Patent US 10,010,081
Granted Patent B2
US 10,010,081 · App. 15/454,859 · Granted Jul 3, 2018

Synergistic antimicrobial preparations containing chlorite and hydrogen peroxide

Inventor: Hampar L. Karageozian (San Juan Capistrano, CA)
Assignee: S.K. PHARMACEUTICALS, INC.
A01N59/00A61K9/0014A61K9/0048A61K31/728A61K33/00A61K33/14A61K33/20A61K33/22A61K33/40A61L12/10A61L12/124
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,010,081
App. No.
15/454,859
Granted
Jul 3, 2018
Kind
B2
Abstract

An anti-microbial preservative for use in ophthalmic and dermatologic products. The preservative includes from about 0.005 wt. % to about 0.20 wt. % chlorite compound and from about 0.005 wt. % to about 0.05 wt. % peroxy compound. Additionally, the preservative does not generate chlorine dioxide within the pH range of 5.0-8.8. Also included are an antimicrobial ophthalmic and dermatologic compositions for direct application onto an eye or skin of a living being including from about 0.005 wt. % to about 0.20 wt. % chlorite compound and from about 0.005 wt. % to about 0.05 wt. % peroxy compound. Also included are methods for treating dryness of the eyes and skin disorders (e.g., wounds, burns, infections, ulcerations, psoriasis, etc.) and for disinfecting and cleansing contact lenses while in place upon an eye by applying the composition to the eye or to the contact lens.

Claims (11)

1. An anti-microbial ophthalmic composition, the composition consisting from about 0.001 wt. % to about 0.20 wt. % chlorite compound and from about 0.0002 wt. % to about 0.05 wt. % peroxy compound, wherein the composition does not contain chlorine dioxide prior to contact with the eye of an individual, and wherein the ophthalmic composition is at a pH range of between 5.0 and 8.8.

2. The anti-microbial ophthalmic composition of claim 1 , wherein the chlorite compound is a metal chlorite.

3. The anti-microbial ophthalmic composition of claim 2 , wherein the metal is sodium.

4. The anti-microbial ophthalmic composition of claim 2 , wherein the metal is metal is selected from the group consisting of potassium, calcium, and magnesium.

5. The anti-microbial ophthalmic composition of claim 1 , wherein the peroxy compound is hydrogen peroxide.

6. The anti-microbial ophthalmic composition of claim 1 , wherein the composition is applied onto an eye for treating dryness of an eye.

7. The anti-microbial ophthalmic composition of claim 1 , wherein the composition is applied onto an eye for treating an infection of an eye.

8. The anti-microbial ophthalmic composition of claim 7 , wherein the infection is caused by a bacterial keratitis.

9. The anti-microbial ophthalmic composition of claim 7 , wherein the infection is caused by a virus.

10. The anti-microbial ophthalmic composition of claim 7 , wherein the infection is caused by a fungus.

11. The anti-microbial ophthalmic composition of claim 1 , wherein the composition is applied onto a contact lens in place on the eye.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 9, 2017
From: KARAGOEZIAN, HAMPAR L.
To: S.K. PHARMACEUTICALS, INC.
Reel/Frame 041532/0575 →
Continuity (10)
Continuation 14718852 · May 21, 2015
Continuation 14307706 · Jun 18, 2014
Continuation 13658609 · Oct 23, 2012
Continuation 12879989 · Sep 10, 2010
Division 12874443 · Sep 2, 2010
Continuation 11633355 · Dec 4, 2006
Continuation In Part 10614646 · Jul 7, 2003
Continuation In Part 09911638 · Jul 23, 2001
Continuation In Part 09412174 · Oct 4, 1999
Related Publication 20170172150A1 · Jun 22, 2017
Cited By (2)
US 12,402,628 US 12,582,123